blog_resources05-e1590646426150
Gastroenterology private equity acquisitions grew 28% in 2021: 5 stats to know (Becker’s ASC Review)
Consolidation in gastroenterology accelerated in 2021, according to a recent report jointly published by consulting firm Fraser Healthcare and pharma research firm Spherix Global Insights.
GI physicians can stay independent while partnering with hospitals, says exec (Becker’s GI & Endoscopy)
Tracy Belsan, market president for Jamison, Pa.-based PE GI Solutions, talks about the importance of independence among gastroenterologists.
This SF Based Startup is Working on Cloud Video and AI for Colonoscopies and Other GI Endoscopy (Marketechpost)
The leading AI startup for endoscopy video automation recently closed their Series A funding round, led by FCA Venture Partners.
Digestive breath tester launched for gastrointestinal conditions (Medtech News)
FoodMarble, a digital health company in the gastroenterology space, has launched a personal digestive breath tester: AIRE 2.
Novel diagnostic platform offers hope for early detection of cancer in patients with Barrett’s esophagus (News-Medical)
University of Colorado (CU) Cancer Center is leading a study to see if a novel diagnostic platform can help endoscopists better identify the disease in patients.
Primer Message Boosts Colorectal Cancer Screening Rates (Medscape)
Researchers have found a simple, low-cost way to get more adults to complete a fecal immunochemical test (FIT) to screen for colorectal cancer (CRC).
Open- label placebo reduces pain in pediatric, adolescent functional GI disorders (Healio)
Open-label placebo reduced pain and rescue medication use among pediatric and adolescent patients with functional abdominal pain and IBS
Follow the Money: AI in GI Research, Cloud Infrastructure Provisioning (Bio.IT World)
The article enlists recent developments and fundings directed towards Artificial Intelligence in Gastroenterology research
AGA fights policies that burden GI practices and delay patient care (AGA)
According to AGA members’ advocacy priorities for 2022 the #1 is reducing the administrative burdens that delay patient care.
AGA clinical practice update: Managing refractory gastroparesis (MDedge)
A new clinical practice update aims to help physicians treat medically refractory gastroparesis with practical advice stemming from expert opinion and a literature review.
Gastroenterology’s Evolving Role in the Management of GI Malignancies (Targeted Oncology)
In an interview with Toufic Kachaamy, MD, discusses in detail the role of the GI community in staging, diagnosing, and managing GI malignancies.
FDA Clears Ambu’s Single-Use Gastroscope (Single Use Endoscopy)
A single-use gastroscope has received 510(k) clearance from the U.S. FDA and could be on the market in the next few months.
Key 2022 Health Care Regulatory and Policy Priorities to Navigate (Health IT Answers)
The article offers a sneak peek of expected 2022 Healthcare regulatory and policy priorities.
Noninvasive Tests to Risk Stratify Patients With Fatty Liver Disease (Expert Perspectives)
The idea is to develop and use noninvasive tests to identify those patients with NAFLD who will progress to develop cirrhosis and liver-related morbidity and mortality.
Buy-and-bill gastroenterologists more likely to offer ancillary services (Becker’s GI & Endoscopy)
“Buy and bill” is a process in which a healthcare provider/ practice purchases, stores and administers therapy to a patient, then submits a reimbursement claim to a third-party payer.
Anesthesia Care Team May Be Quicker for GI Endoscopy (Medscape)
Gastrointestinal (GI) endoscopy takes less time when an anesthesiologist oversees the sedation, researchers say.
Crohn’s and Colitis Congress roundup: Intestinal ultrasound, cultural barriers in IBD (Healio)
Topics include the effectiveness of intestinal ultrasound, cultural barriers in IBD care, therapeutics coming down the IBD pipeline, and more.
Towards health equity: the urgent need for upstream intervention studies in gastroenterology and hepatology (The Lancet GI & Hepatology)
Interventions to reduce health inequity can be individual health-care needs, neighbourhood conditions, or structural racism and discrimination.
Guardant Health targets colorectal cancer screening in 2022 (MedTech Dive)
CEO Helmy Eltoukhy said that the precision oncology company aims to launch a liquid biopsy in the first half, rivaling Exact Sciences’ Cologuard stool test.

 

What’s on The Horizon for 2022: Trends in Global Healthcare Private Equity   (National Law Review)
The healthcare sector has seen enormous enthusiasm and infusion of funds during the pandemic, and the pace of transactions shows no signs of slowing anytime soon.                                                                                                 

More Hot headlines in GI
Mayo Clinic Cancer Center researchers identify promising drug to treat gastrointestinal cancers (Mayo Clinic)
Gut Microbiota for Health World Summit 2022 (MDedge)
Top Expert Pediatric Gastroenterology and Nutrition Dr. Carlos Lifschitz joins ELSE’s Scientific Advisory Board (Yahoo Finance)
Deloitte invests $750M in healthcare, consumer and financial services businesses (MedCity News)
Tackling Colorectal Cancer Drug Resistance by Reversing Chemorefraction
(Genetic Engineering & Biotechnology News)
Gut Microbiota for Health World Summit 2022 (MDedge)
Program may boost colorectal cancer screening among Hispanic adults and reduce related gender disparities (Medical Xpress)
Three-drug combination active in metastatic colorectal cancer subset (Healio)
Videos: Interviews with GI Leaders  (NextServices)